Your session is about to expire
← Back to Search
Behavioural Intervention
Cognitive-Behavioral Therapy for Opioid Use Disorder
N/A
Recruiting
Led By Michelle R Lent, PhD
Research Sponsored by Philadelphia College of Osteopathic Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial tests if a 12-week therapy can help people with opioid use disorder stop or reduce illicit opioid use. Participants get therapy from a counselor and are assessed before and after.
Who is the study for?
This trial is for adults over 18 living with opioid use disorder who want to reduce or stop using opioids. They must be able to consent and receive therapy in English, not under legal supervision like a halfway house.Check my eligibility
What is being tested?
The study tests a structured 12-week cognitive-behavioral therapy program aimed at treating opioid addiction. Participants will undergo weekly sessions with a counselor and have their mood and recovery support perceptions evaluated.See study design
What are the potential side effects?
Cognitive-behavioral therapy doesn't typically cause physical side effects but can sometimes lead to emotional discomfort as individuals confront difficult aspects of their condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Urinalysis-confirmed Reduction or Elimination of Illicit Opioid Use
Secondary outcome measures
The Brief Assessment of Recovery Capital (BARC-10)
The Client Satisfaction Questionnaire-8 (CSQ-8)
The Patient Health Questionnaire-9 (PHQ-9)
Trial Design
1Treatment groups
Experimental Treatment
Group I: 12 Week Manualized Cognitive-Behavioral Therapy InterventionExperimental Treatment1 Intervention
Participants will receive a once-per-week, 12 week manualized cognitive-behavioral therapy intervention.
Find a Location
Who is running the clinical trial?
Philadelphia College of Osteopathic MedicineLead Sponsor
9 Previous Clinical Trials
1,337 Total Patients Enrolled
Prevention Point PhiladelphiaUNKNOWN
1 Previous Clinical Trials
104 Total Patients Enrolled
Michelle R Lent, PhDPrincipal InvestigatorPhiladelphia College of Osteopathic Medicine
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any unoccupied positions available for participation in this trial?
"Based on available records, this experiment is presently recruiting participants. It was first opened to the public on August 6th 2023 and recently updated in mid-August of that same year."
Answered by AI
What is the participation capacity of this clinical trial?
"Affirmative. Per clinicaltrials.gov, the data reveals this medical trial is currently recruiting participants; it was first posted on August 6th 2023 and last revised on August 17th 2023. The study necessitates enlisting 20 patients from one centre ."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger